Thanks Hottod, some questions to start the new year that will be great to get yours or other members thoughts on! Here they are;
1) Will CPP-PMO herald a new exon-skipping branch of genetic precision medicine?
2) Will PYC be the first to profess leads clinically across multiple modalities (brain, eye, kidney)?
3) What’s the $ value for each PYC’s individual programs and what’s the $ value of the platform if it proven?
thank you!
Ann: Successful Toxicology Studies Pave Way for Human Trials, page-61
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |